April - June 2019, Volume 15, Issue 2

Tasci ES, Eralp H, Kayatas K

Lithium-Induced Nephrogenic Diabetes Insipidus Responsive to Desmopressin

Acta Endo (Buc) 2019, 15 (2): 270-271
doi: 10.4183/aeb.2019.270

Nephrogenic diabetes insipidus (NDI) is the most common renal side effect seen with lithium therapy. Persisting cases after the cessation of the therapy may be seen when lithium therapy is continued for too long. Although desmopressin treatment is not one of the accepted treatment modalities for NDI, there are few reports using desmopressin treatment in unresponsive cases. Herein, we reported the fourth lithium-induced NDI case in the literature responsive to desmopressin therapy.

Keywords: desmopressin, diabetes insipidus, lithium, nephrogenic.

Correspondence: Eli?f Senocak Tasç MD, Duzce University, Duzce, E-mail: esenocak@gmail.com